Gilead Sciences Q1 Profit Rises - Quick Facts

(RTTNews) - Gilead Sciences, Inc. (GILD) reported first quarter net income of $4.3 billion or $2.76 per share, compared to $2.2 billion or $1.33 per share, prior year. Adjusted earnings per share was $2.94, for the quarter.

On average, 21 analysts polled by Thomson Reuters expected the company to report profit per share of $2.32 for the quarter. Analysts' estimates typically exclude special items.

Product sales were $7.41 billion, compared to $4.87 billion. Revenue increased to $7.59 billion from $5.00 billion last year. Analysts expected revenue of $6.92 billion for the quarter. Gilead updated its full year 2015 guidance, which it initially provided on February 3, 2015. Net Product Sales are now expected to be $28.00 billion to $29.00 billion, compared to prior guidance of $26.00 billion to $27.00 billion. Analysts expect the company to report fiscal 2015 revenue of $28.50 billion.